Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-08

Clinical Trial Update: Safety and Efficacy of Vilazodone in Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of vilazodone for major depressive disorder has been completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-08-08